Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Insulin Immunologic Effects in T1D Risk
NCT02580877Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2016
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of regular human insulin in type 1 diabetes mellitus (T1D), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2016; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02580877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580877.